Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Stocks were indicated higher on Tuesday morning after 5 days in a row of selling. Yet again we see the trend of investors finding a reason to buy every stock ...
Read Full Story »
Biotechnology word cloud

Have Analysts Fully Priced in Praluent to Regeneron?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Exxon, LifeLock, Microsoft, PayPal, Chipotle and More

Stocks were lower on Wednesday morning as investors are selling more earnings reports. Still, the one trend that has held up for almost four years now is that investors have ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Stocks were looking for direction on Tuesday as the earnings onslaught begins. One trend that has held up for almost four years now is that investors have bought every stock ...
Read Full Story »
amgnlogo

4 Large Cap Biotech Stocks to Buy Before Earnings

The biotech industry has been on an outstanding run over the past year, and some top analysts on Wall Street think that run could be poised to continue. A new ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Envestnet, Pandora, Regeneron, Spectra, Travelers and More

Stocks were indicated up sharply on Thursday morning as China banned large stakeholders and insiders from selling shares in an effort to stop the sell-off. Yet again, the trend that ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
New Netflix Logo

Is It Time to Stop Chasing Netflix Higher?

Remember back in the day when Netflix Inc. (NASDAQ: NFLX) collapsed 80% in less than five months, from $295 to $63 a share? That was in 2011. It was catastrophic. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Exxon, Home Depot, Lululemon, 3M, Vodafone, Mondelez, Chevron and More

Stocks were marginally lower on Monday to kick off the week, after the prior week was in the red. The one trend that is nearly four years old is that ...
Read Full Story »
145922793

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. This covers a new class of drugs in the PCSK9 classification, and FDA panels are ...
Read Full Story »
GettyImages_183162370

Large Companies With Fastest Revenue and Earnings Growth in 2015

This year is nearing the halfway mark and analysts are beginning to project their biggest winners and losers on the year. S&P Capital IQ recently released a report regarding the ...
Read Full Story »
biotech

The Most Loved Biotechs of Big Hedge Funds

With such a mixed performance over the past decade, some of us wonder why hedge funds are so revered. Ditto for many of the so-called guru fund managers. Still, investors ...
Read Full Story »
buy sell

5 Stocks Investors Must Watch in the Week Ahead

Stocks took a break from the six-year-old bull market last week. Still, investors want to own stocks, and they have aggressively bought every single sell-off for almost three years. 24/7 ...
Read Full Story »
biotech

The 5 Most Loved Biotech Stocks of Portfolio Managers

With the market continuing to grind higher, and the memories of the first time the Nasdaq hit 5,000 getting a fair amount of airplay and commentary, the question for most ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Box, BBVA, Freescale, Micron, Nordstrom and More

24/7 Wall St. reviews many fresh research calls each and every morning to find new investing and trading ideas for its readers. Some research reports cover stocks to Buy. Other ...
Read Full Story »